FDA Inspection 1220651 — Lindsay Harrison, MD

Lindsay Harrison, MD — FEI 3027631695

The FDA completed an inspection of Lindsay Harrison, MD on Oct 5, 2023 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 5, 2023
Fiscal Year
2024
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Austin, TX (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.